United StatesÚltimas notícias

SpaceX is heading for the biggest IPO ever. Bloomberg's Bailey Lipschultz and Sridhar Natarajan join Bloomberg Open Interest to break down how Wall Street is preparing for the historic debut. Demand is already huge, but the real question is whether SpaceX's massive offering helps reopen the IPO market, or just makes it even harder for everyone else.

Latam Airlines CEO Roberto Alvo says that high fuel prices could lead to capacity cuts and South American taxes are keeping some travelers out of the skies. Alvo spoke with Bloomberg's Guy Johnson on the sidelines of the IATA 2026 Conference.

There's a case for the Federal Reserve to "hike right now,'' and even if policymakers aren't ready yet, the bar to action is definitely getting lower, according to Collin Martin at the Schwab Center for Financial Research. He speaks with Jonathan Ferro and Annmarie Hordern on Bloomberg Television's "Surveillance.''

Southwest Airlines Chief Operating Officer Andrew Watterson says business travel has remained "incredibly strong" despite higher costs related to the War in Iran. He speaks with Lisa Abramowicz on the sidelines of the IATA Conference in Brazil.

Alphabet's Google placed an order with Intel to manufacture more than 3 million of its specialized AI chips in 2028, the Information reported, citing two unnamed sources. Anurag Rana has more on "Bloomberg Open Interest."

Optical Cable (NASDAQ:OCC) reported a sharp turnaround in its second-quarter financial results for fiscal year 2026, driven by accelerating top-line growth and a substantial expansion of its product backlog.

Novo Nordisk (NYSE:NVO) announced that prescriptions for the oral version of Wegovy have exceeded 3 million since the product’s U.S. market introduction in January 2026.

Elon Musk wants to build the infrastructure for AI in space and he's asking investors to help pay for it. The rocket, satellite and now AI company wants to raise around 75 billion dollars in what could become the largest IPO in history, funding everything from its Starship rocket to AI computing power and future data centers in orbit. Bloomberg Tech's Ed Ludlow takes a look at what's at stake.

Johnson & Johnson (NYSE:JNJ) announced today that it has entered into a definitive agreement to acquire Firefly Bio for $1 billion in cash.

MetaVia (NASDAQ:MTVA) has reported new data from its cardiometabolic pipeline at the American Diabetes Association’s (ADA) 2026 Scientific Sessions in New Orleans.

Neurocrine Biosciences (NASDAQ:NBIX) has announced new clinician-reported data highlighting the effectiveness of INGREZZA (valbenazine) in treating tardive dyskinesia (TD) among individuals with intellectual and developmental disabilities (IDD).

Galmed Pharmaceuticals (NASDAQ:GLMD) has entered into a definitive agreement to acquire Colospan, a commercial-stage medical device company specializing in gastrointestinal surgery solutions.